Table of Content

Table of Contents

Global Metastatic Melanoma Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 AGI-134 -Product Introduction and Major Manufacturers
1.1.2 ALT-801 -Product Introduction and Major Manufacturers
1.1.3 ALT-803 -Product Introduction and Major Manufacturers
1.1.4 AMG-232 -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.1.1 China Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.2.1 EU Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.3.1 USA Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.4.1 Japan Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.5.1 India Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.7.1 South America Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Metastatic Melanoma Drug Status and Prospect (2015-2026)
2.8.1 Metastatic Melanoma Drug Market Size and Growth Rate (2015-2026)
2.8.2 Metastatic Melanoma Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Metastatic Melanoma Drug Market Assessment by Segment
3.1 Global Metastatic Melanoma Drug Capacity and Growth Rate
3.2 Global Metastatic Melanoma Drug Sales by Type
3.3 Global Metastatic Melanoma Drug Sales Revenue by Type
3.4 Global Metastatic Melanoma Drug Consumption by Application
4 Global Metastatic Melanoma Drug Market Assessment by Regions
4.1 Global Metastatic Melanoma Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Metastatic Melanoma Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Metastatic Melanoma Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Metastatic Melanoma Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Metastatic Melanoma Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Metastatic Melanoma Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Metastatic Melanoma Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Metastatic Melanoma Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Metastatic Melanoma Drug Competitive Analysis
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Company Profiles
7.1.2 Merck & Co., Inc. Product Introduction
7.1.3 Merck & Co., Inc. Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Merck KGaA
7.2.1 Merck KGaA Company Profiles
7.2.2 Merck KGaA Product Introduction
7.2.3 Merck KGaA Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Millennium Pharmaceuticals, Inc.
7.3.1 Millennium Pharmaceuticals, Inc. Company Profiles
7.3.2 Millennium Pharmaceuticals, Inc. Product Introduction
7.3.3 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Morphotek, Inc.
7.4.1 Morphotek, Inc. Company Profiles
7.4.2 Morphotek, Inc. Product Introduction
7.4.3 Morphotek, Inc. Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 NewLink Genetics Corporation
7.5.1 NewLink Genetics Corporation Company Profiles
7.5.2 NewLink Genetics Corporation Product Introduction
7.5.3 NewLink Genetics Corporation Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Novartis AG
7.6.1 Novartis AG Company Profiles
7.6.2 Novartis AG Product Introduction
7.6.3 Novartis AG Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Omeros Corporation
7.7.1 Omeros Corporation Company Profiles
7.7.2 Omeros Corporation Product Introduction
7.7.3 Omeros Corporation Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Oncolytics Biotech Inc.
7.8.1 Oncolytics Biotech Inc. Company Profiles
7.8.2 Oncolytics Biotech Inc. Product Introduction
7.8.3 Oncolytics Biotech Inc. Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 OncoSec Medical Inc.
7.9.1 OncoSec Medical Inc. Company Profiles
7.9.2 OncoSec Medical Inc. Product Introduction
7.9.3 OncoSec Medical Inc. Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Ono Pharmaceutical Co., Ltd.
7.10.1 Ono Pharmaceutical Co., Ltd. Company Profiles
7.10.2 Ono Pharmaceutical Co., Ltd. Product Introduction
7.10.3 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Pfizer Inc.
7.12 Pharmis Biofarmaceutica, Lda.
7.13 Philogen S.p.A.
7.14 Plexxikon Inc.
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Metastatic Melanoma Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Metastatic Melanoma Drug Sales (K Unit) by Type (2015-2026)
Figure Global Metastatic Melanoma Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Metastatic Melanoma Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Metastatic Melanoma Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Metastatic Melanoma Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Metastatic Melanoma Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Metastatic Melanoma Drug Sales (K Unit) by Application (2015-2026)
Figure China Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Metastatic Melanoma Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Metastatic Melanoma Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Metastatic Melanoma Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Metastatic Melanoma Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Metastatic Melanoma Drug Sales (Unit) by Type (2015-2026)
Figure Global Metastatic Melanoma Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Metastatic Melanoma Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Metastatic Melanoma Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Metastatic Melanoma Drug Consumption (Unit) by Application (2015-2026)
Figure Global Metastatic Melanoma Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Metastatic Melanoma Drug Production (K Unite) by Regions (2015-2020)
Table Global Metastatic Melanoma Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Metastatic Melanoma Drug Production Share by Regions (2019-2020)
Table Global Metastatic Melanoma Drug Sales (K Unite) by Regions (2015-2020)
Table Global Metastatic Melanoma Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Metastatic Melanoma Drug Sales Share by Regions (2019-2020)
Table Global Metastatic Melanoma Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Metastatic Melanoma Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Metastatic Melanoma Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Metastatic Melanoma Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Metastatic Melanoma Drug
Figure Cost Structure of Metastatic Melanoma Drug in 2020
Table Global Metastatic Melanoma Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Metastatic Melanoma Drug Capacity Share of Manufacturers (2019-2020)
Table Global Metastatic Melanoma Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Metastatic Melanoma Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Metastatic Melanoma Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Metastatic Melanoma Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Metastatic Melanoma Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Merck & Co., Inc. Profiles
Table ????Merck & Co., Inc. Metastatic Melanoma Drug Product Introduction
Table ????Merck & Co., Inc. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Merck & Co., Inc. SWOT Analysis
Table ????Merck KGaA Profiles
Table ????Merck KGaA Metastatic Melanoma Drug Product Introduction
Table ????Merck KGaA Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Merck KGaA SWOT Analysis
Table ????Millennium Pharmaceuticals, Inc. Profiles
Table ????Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Product Introduction
Table ????Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Millennium Pharmaceuticals, Inc. SWOT Analysis
Table ????Morphotek, Inc. Profiles
Table ????Morphotek, Inc. Metastatic Melanoma Drug Product Introduction
Table ????Morphotek, Inc. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Morphotek, Inc. SWOT Analysis
Table ????NewLink Genetics Corporation Profiles
Table ????NewLink Genetics Corporation Metastatic Melanoma Drug Product Introduction
Table ????NewLink Genetics Corporation Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????NewLink Genetics Corporation SWOT Analysis
Table ????Novartis AG Profiles
Table ????Novartis AG Metastatic Melanoma Drug Product Introduction
Table ????Novartis AG Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Novartis AG SWOT Analysis
Table ????Omeros Corporation Profiles
Table ????Omeros Corporation Metastatic Melanoma Drug Product Introduction
Table ????Omeros Corporation Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Omeros Corporation SWOT Analysis
Table ????Oncolytics Biotech Inc. Profiles
Table ????Oncolytics Biotech Inc. Metastatic Melanoma Drug Product Introduction
Table ????Oncolytics Biotech Inc. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Oncolytics Biotech Inc. SWOT Analysis
Table ????OncoSec Medical Inc. Profiles
Table ????OncoSec Medical Inc. Metastatic Melanoma Drug Product Introduction
Table ????OncoSec Medical Inc. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????OncoSec Medical Inc. SWOT Analysis
Table ????Ono Pharmaceutical Co., Ltd. Profiles
Table ????Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Product Introduction
Table ????Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Ono Pharmaceutical Co., Ltd. SWOT Analysis
Table ????Pfizer Inc. Profiles
Table ????Pfizer Inc. Metastatic Melanoma Drug Product Introduction
Table ????Pfizer Inc. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Pfizer Inc. SWOT Analysis
Table ????Pharmis Biofarmaceutica, Lda. Profiles
Table ????Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Product Introduction
Table ????Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Pharmis Biofarmaceutica, Lda. SWOT Analysis
Table ????Philogen S.p.A. Profiles
Table ????Philogen S.p.A. Metastatic Melanoma Drug Product Introduction
Table ????Philogen S.p.A. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Philogen S.p.A. SWOT Analysis
Table ????Plexxikon Inc. Profiles
Table ????Plexxikon Inc. Metastatic Melanoma Drug Product Introduction
Table ????Plexxikon Inc. Metastatic Melanoma Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Plexxikon Inc. SWOT Analysis